Articles about 'Dami Collier'

The Pfizer BioNTech vaccine BNT162b2 is likely to be effective against the B1.1.7 variant of SARS-CoV-2, even though its efficacy is modestly affected, say scientists at the University of Cambridge. However, when the E484K mutation – first seen in the South African variant – is added, it substantially increases the amount of antibody required to prevent infection.

Researchers say faster tests helped expedite access to life-saving treatments such as organ transplants – and might make all the difference later this year.